You searched for
We found 9 articles
Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis.
The purposes of this study are to determine: 1. Whether drotrecogin alfa (activated) helps children with severe sepsis survive their…
01 Jan 2013
Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus after Allogeneic Stem Cell Transplant
Patients enrolled on this study have a type of blood cell cancer, other blood disease or a genetic disease for…
01 Jan 2013
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
OBJECTIVES: I. Compare the efficacy and safety of two doses of oral valacyclovir in immunocompromised patients with uncomplicated herpes zoster.
01 Jan 2013
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
RATIONALE: Tipifarnib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase…
01 Jan 2013
Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
01 Jan 2013
Intensified chemotherapy shows promise for children with very high-risk form of leukaemia
Young patients with an aggressive form of leukaemia who are likely to relapse after chemotherapy treatment can significantly reduce those…
21 Dec 2012
B cell
B cells, also known as B-lymphocytes, are lymphocytes produced in the bone marrow which circulate in the bloods and form…
01 Jan 2012
Erythropoietin (EPO)
Erythropoietin (EPO) is a protein which interacts with receptors on the surface of the primitive bone marrow cells. Erythropoietins…
01 Jan 2012
